Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, Heat Shock Protein 90 | 0 | 0 | 1 | 1 |
Chain A, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE | 0 | 0 | 1 | 1 |
Chain B, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE | 0 | 0 | 1 | 1 |
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
Chain A, Myosin Ie Heavy Chain | 0 | 0 | 1 | 1 |
Chain A, Preprotein translocase secA | 0 | 0 | 1 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Phosphoribosylformylglycinamidine synthase | 0 | 1 | 0 | 1 |
Chain A, nucleoside diphosphate kinase A | 0 | 0 | 1 | 1 |
Chain B, nucleoside diphosphate kinase A | 0 | 0 | 1 | 1 |
Chain D, DNA polymerase III subunit gamma | 0 | 0 | 1 | 1 |
Chain D, DNA polymerase III subunit gamma | 0 | 0 | 1 | 1 |
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3 | 0 | 0 | 1 | 1 |
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3 | 0 | 0 | 1 | 1 |
Chain A, Kinesin-like protein KIF11 | 0 | 1 | 0 | 1 |
regulator of G-protein signaling 4 | 1 | 0 | 0 | 1 |
HPr kinase/phosphorylase | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 1 | 1 |
ATP-dependent molecular chaperone HSP82 | 0 | 0 | 0 | 1 |
Heat shock protein HSP 90-alpha | 0 | 1 | 1 | 3 |
Heat shock protein HSP 90-beta | 0 | 1 | 1 | 3 |
2-dehydropantoate 2-reductase | 0 | 1 | 1 | 2 |
Heat shock 70 kDa protein 1A | 0 | 1 | 1 | 2 |
Endoplasmic reticulum chaperone BiP | 0 | 0 | 1 | 1 |
Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
Pyruvate kinase PKM | 0 | 0 | 0 | 1 |
Pyruvate kinase PKLR | 0 | 0 | 0 | 1 |
Endoplasmin | 0 | 0 | 0 | 1 |
Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
5'-nucleotidase | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 0 | 1 | 1 |
Delta-type opioid receptor | 0 | 0 | 1 | 1 |
Kappa-type opioid receptor | 0 | 0 | 1 | 1 |
Endoplasmin | 0 | 1 | 1 | 2 |
P2Y purinoceptor 2 | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 2 |
P2X purinoceptor 1 | 0 | 0 | 1 | 1 |
P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
P2X purinoceptor 1 | 0 | 0 | 1 | 1 |
P2X purinoceptor 4 | 0 | 0 | 1 | 1 |
P2X purinoceptor 5 | 0 | 0 | 1 | 1 |
P2X purinoceptor 6 | 0 | 0 | 1 | 1 |
P2X purinoceptor 3 | 0 | 0 | 1 | 1 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
Heat shock protein 75 kDa, mitochondrial | 0 | 1 | 0 | 1 |
P2Y purinoceptor 6 | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 2 |
P2Y purinoceptor 11 | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 2 |
P2Y purinoceptor 12 | 0 | 0 | 1 | 1 |
Sensor protein kinase WalK | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 2 |
P2X purinoceptor 2 | 0 | 0 | 1 | 1 |
Chain A, Vitamin D Nuclear Receptor | 0 | 0 | 1 | 1 |
Chain A, Beta-lactamase | 2 | 0 | 0 | 2 |
Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
Vitamin D3 receptor | 0 | 0 | 1 | 1 |
USP1 protein, partial | 3 | 0 | 0 | 3 |
PPM1D protein | 1 | 0 | 0 | 1 |
Microtubule-associated protein tau | 2 | 0 | 0 | 2 |
thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
euchromatic histone-lysine N-methyltransferase 2 | 7 | 0 | 0 | 7 |
mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 2 | 0 | 0 | 2 |
geminin | 6 | 0 | 0 | 6 |
peripheral myelin protein 22 | 2 | 0 | 0 | 2 |
ATP-binding cassette sub-family C member 3 | 0 | 2 | 0 | 2 |
Multidrug resistance-associated protein 4 | 0 | 2 | 0 | 2 |
Bile salt export pump | 0 | 5 | 0 | 5 |
Interferon beta | 2 | 0 | 0 | 2 |
Vitamin D-binding protein | 0 | 0 | 1 | 1 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 2 |
Cytochrome P450 3A4 | 0 | 3 | 0 | 4 |
Androgen receptor | 0 | 1 | 0 | 1 |
Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
Vitamin D3 receptor | 0 | 2 | 3 | 9 |
Cytochrome P450 2C9 | 0 | 1 | 0 | 2 |
Vitamin D3 receptor | 0 | 1 | 1 | 3 |
Retinoic acid receptor RXR-alpha | 0 | 0 | 3 | 3 |
Cytochrome P450 2C19 | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 0 | 1 | 1 |
Vitamin D3 receptor | 0 | 0 | 2 | 2 |
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 0 | 1 | 1 |
Vitamin D3 receptor | 0 | 1 | 1 | 2 |
Transporter | 0 | 1 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 2 | 0 | 2 |
Vitamin D3 receptor A | 0 | 0 | 2 | 2 |
Chain A, HADH2 protein | 1 | 0 | 0 | 1 |
Chain B, HADH2 protein | 1 | 0 | 0 | 1 |
Chain A, Cruzipain | 1 | 0 | 0 | 1 |
Luciferase | 2 | 0 | 0 | 2 |
interleukin 8 | 1 | 0 | 0 | 1 |
15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
AR protein | 5 | 0 | 0 | 5 |
aldehyde dehydrogenase 1 family, member A1 | 3 | 0 | 0 | 3 |
glucocorticoid receptor [Homo sapiens] | 2 | 0 | 0 | 2 |
retinoid X nuclear receptor alpha | 4 | 0 | 0 | 4 |
farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
pregnane X nuclear receptor | 3 | 0 | 0 | 3 |
estrogen nuclear receptor alpha | 7 | 0 | 0 | 7 |
peroxisome proliferator-activated receptor delta | 2 | 0 | 0 | 2 |
peroxisome proliferator activated receptor gamma | 4 | 0 | 0 | 4 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 1 | 0 | 0 | 1 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform a | 3 | 0 | 0 | 3 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 5 | 0 | 0 | 5 |
DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
cytochrome P450 3A4 isoform 1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 2 | 0 | 0 | 2 |
Cellular tumor antigen p53 | 4 | 0 | 0 | 4 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
60 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 2 | 0 | 0 | 2 |
Glycine receptor subunit alpha-1 | 0 | 0 | 2 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 2 | 0 | 0 | 2 |
Nuclear receptor ROR-gamma | 1 | 0 | 0 | 1 |
10 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-2 | 2 | 0 | 0 | 2 |
Thiosulfate sulfurtransferase | 0 | 2 | 0 | 2 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
10 kDa chaperonin | 0 | 2 | 0 | 2 |
GABA theta subunit | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit epsilon | 2 | 0 | 0 | 2 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
RAR-related orphan receptor gamma | 5 | 0 | 0 | 5 |
nuclear receptor subfamily 1, group I, member 3 | 2 | 0 | 0 | 2 |
progesterone receptor | 2 | 0 | 0 | 2 |
retinoic acid nuclear receptor alpha variant 1 | 2 | 0 | 0 | 2 |
estrogen-related nuclear receptor alpha | 4 | 0 | 0 | 4 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 3 | 0 | 0 | 3 |
Histone H2A.x | 1 | 0 | 0 | 1 |
Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 2 | 0 | 0 | 2 |
Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Glutamate receptor 2 | 2 | 0 | 0 | 2 |
Histamine H2 receptor | 1 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase VIM-1 | 0 | 1 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 1 | 3 |
Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 1 | 3 |
Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 1 | 3 |
Proton-coupled amino acid transporter 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 1 | 3 |
Serine racemase | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 1 | 3 |
Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
Asc-type amino acid transporter 1 | 0 | 1 | 0 | 1 |
Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
Amino acid transporter | 0 | 1 | 0 | 1 |
acetylcholinesterase | 1 | 0 | 0 | 1 |
aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 2 | 0 | 0 | 2 |
activating transcription factor 6 | 1 | 0 | 0 | 1 |
histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
thioredoxin reductase | 4 | 0 | 0 | 4 |
GALC protein | 2 | 0 | 0 | 2 |
GLI family zinc finger 3 | 3 | 0 | 0 | 3 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 3 | 0 | 0 | 3 |
chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
lamin isoform A-delta10 | 3 | 0 | 0 | 3 |
Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
Aromatase | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Cytochrome P450 11B2, mitochondrial | 0 | 1 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 2 | 0 | 0 | 2 |
glp-1 receptor, partial | 1 | 0 | 0 | 1 |
TDP1 protein | 4 | 0 | 0 | 4 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
IDH1 | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
Vpr | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
Spike glycoprotein | 1 | 0 | 0 | 1 |
chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 0 | 1 |
Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Polyphenol oxidase 2 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 12 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
Bile salt export pump | 0 | 1 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Albumin | 0 | 1 | 0 | 1 |
Polymerase acidic protein | 0 | 0 | 1 | 1 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Stromelysin-1 | 0 | 0 | 1 | 1 |
Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
High mobility group protein B1 | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 3 |
Estrogen receptor | 0 | 0 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 6 | 0 | 1 | 0 | 1 |
Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 1 | 0 | 0 | 1 |
Cereblon isoform 4 | 0 | 2 | 0 | 2 |
EWS/FLI fusion protein | 2 | 0 | 0 | 2 |
cytochrome P450 2D6 | 1 | 0 | 0 | 1 |
arylsulfatase A | 1 | 0 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
DNA-binding protein Ikaros | 0 | 0 | 0 | 1 |
DNA damage-binding protein 1 | 0 | 1 | 1 | 2 |
Protein cereblon | 0 | 2 | 1 | 4 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
G | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 2 | 0 | 0 | 2 |
HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
Transthyretin | 0 | 1 | 0 | 2 |
Thyroid hormone receptor alpha | 0 | 0 | 1 | 1 |
Thyroid hormone receptor beta | 0 | 0 | 1 | 1 |
Proliferating cell nuclear antigen | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 2 | 2 |
Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 1 |
Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
Bile acid receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1B1 | 0 | 0 | 0 | 1 |
cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Solute carrier family 2, facilitated glucose transporter member 9 | 0 | 1 | 1 | 2 |
Guanine deaminase | 0 | 1 | 0 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |